References

• Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T. R., Handley, R., Luzi, S., Russo, M., Paparelli, A., Butt, A., Stilo, S. A., Wiffen, B., Powell, J., & Murray, R. M. (2009). High-potency cannabis and the risk of psychosis. The British journal of psychiatry : the journal of mental science, 195(6), 488–491. https://doi.org/10.1192/bjp.bp.109.064220
• Hasin, D. S., Sarvet, A. L., Cerdá, M., Keyes, K. M., Stohl, M., Galea, S., & Wall, M. M. (2017). US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws: 1991–1992 to 2012–2013. JAMA Psychiatry, 74(6), 579–588. https://doi.org/10.1001/jamapsychiatry.2017.0724
• Murray, R. M., Quigley, H., Quattrone, D., Englund, A., & Di Forti, M. (2021). Traditional marijuana, high-potency cannabis and synthetic cannabinoids: Increasing risk for psychosis. World Psychiatry, 20(3), 362–363. https://doi.org/10.1002/wps.20857
• Myran, D. T., Pugliese, M., Harrison, L. D., Solmi, M., Anderson, K. K., Fiedorowicz, J. G., Finkelstein, Y., Manuel, D., Taljaard, M., Webber, C., & Tanuseputro, P. (2025). Changes in incident schizophrenia diagnoses associated with cannabis use disorder after cannabis legalization. JAMA Network Open, 8(2), e2457868. https://doi.org/10.1001/jamanetworkopen.2024.57868
• Substance Abuse and Mental Health Services Administration. (2023). Key substance use and mental health indicators in the United States: Results from the 2022 National Survey on Drug Use and Health (HHS Publication No. PEP23-07-01-006, NSDUH Series H-58). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/report/2022-nsduh-annual-national-report